Topic
CAR T-Cell Therapy
4 Podcasts on BackTable
Episode # 80 • 08 Sept 2026
Scaling Community CAR-T: Operational Lessons & Future Directions
with Dr. Mike Byrne, Aaron Lyss
How does delivering CAR-T in the community change patient care, and what has to happen next for these programs to scale? On this episode of the BackTable Tumor Board Podcast, host Aaron Lyss interviews Dr. Mike Byrne, hematologist at Tennessee Oncology and medical director for cellular therapy at OneOncology, about operational lessons and future directions for outpatient CAR-T therapy. They discuss the impact of faster time to treatment, building trust through local relationships, and the weekly pipeline management that keeps the program moving.
More on CAR T-Cell Therapy
Loading recent podcasts…
Tumor Board # 80
Sep 7, 2026
with Dr. Mike Byrne, Aaron Lyss
How does delivering CAR-T in the community change patient care, and what has to happen next for these programs to...
Tumor Board # 59
May 11, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
Tumor Board # 78
Aug 24, 2026
with Dr. Mike Byrne, Aaron Lyss
Where does access to cell therapy actually break down, and can community practices close the gap? On this episode of...
Curbsiders # 441
May 26, 2024
with Dr. Chris Chiu, Dr. Nora Taranto, Dr. Beth Gasperlin, Dr. Matthew Watto, Dr. Paul Williams
More clinical pearls from ACP #IM2024, including emerging infectious diseases in the US (malaria, dengue, super...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.